What is CUSIP 62921N105?

CUSIP 62921N105 is the security identifier used in SEC filing datasets for NGM - NGM BIOPHARMACEUTICALS INC - COM.

Who owns NGM - NGM BIOPHARMACEUTICALS INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

Security Snapshot

NGM BIOPHARMACEUTICALS INC - COM (NGM) Institutional Ownership

CUSIP: 62921N105

13F Institutional Holders and Ownership History from Q2 2019 to Q2 2024

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Security type / class: Equity / COM
Symbol: NGM

13F Shares, Excluding Options vs Price

13F Value, Excluding Options

Total Investors

Key facts

NGM - NGM BIOPHARMACEUTICALS INC - COM is tracked under CUSIP 62921N105.
Latest finished 13F holder period is not available.
Schedule 13D/13G significant owner rows are not currently available.

Change

Holder count moved from 70 to 0 between Q1 2024 and Q2 2024.
SEC-reported value moved from $54,999,572 to $0.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

62921N105

Latest holder period

n/a

13F holders

13D/G owners

CIK / CUSIP context first

NGM full holder history

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 62921N105:

Q2 2024 (0 holders) Q1 2024 (70 holders) Q4 2023 (79 holders) Q3 2023 (91 holders) Q2 2023 (101 holders) Q1 2023 (121 holders) Q4 2022 (123 holders) Q3 2022 (124 holders) Q2 2022 (116 holders) Q1 2022 (111 holders)

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods

Latest

n/a

Rows shown

1-21 of 21

Period	13F Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2024 Q2	0	$0	-$54,723,051	$0	$0		0
2024 Q1	34,591,504	$54,999,572	-$5,774,913	$318	$1,272	$1.59	70
2023 Q4	41,122,220	$35,321,273	-$5,621,280	$258	$86	$0.86	79
2023 Q3	47,286,277	$50,601,674	-$2,234,506	$321	$428	$1.07	91
2023 Q2	47,982,303	$124,272,246	-$3,211,886	$3,108	$6,216	$2.59	101
2023 Q1	47,197,224	$192,506,190	-$4,758,058	$408	$53,856	$4.08	121
2022 Q4	49,595,426	$248,961,789	-$44,837,115	$3,012	$762,538	$5.02	123
2022 Q3	52,764,683	$690,130,864	+$70,574,503	$450,000	$6,574,000	$13.08	124
2022 Q2	47,362,672	$607,192,137	-$21,648,197		$1,547,000	$12.82	116
2022 Q1	48,055,378	$732,837,689	+$12,060,151		$3,000	$15.25	111
2021 Q4	47,064,729	$833,490,515	+$27,920,648	$0	$1,018,000	$17.71	113
2021 Q3	29,843,007	$627,606,289	+$49,369,343	$2,623,000	$7,918,000	$21.02	117
2021 Q2	39,319,777	$775,411,946	-$8,938,336		$599,000	$19.72	105
2021 Q1	39,267,121	$1,141,407,737	+$164,908,439		$1,398,000	$29.07	102
2020 Q4	33,339,501	$1,010,134,414	+$27,899,518		$648,000	$30.30	87
2020 Q3	30,436,879	$484,291,987	+$5,934,350		$210,000	$15.91	78
2020 Q2	30,000,648	$592,206,185	+$34,248,759		$2,000	$19.74	78
2020 Q1	32,276,256	$397,969,642	+$33,512,358			$12.33	71
2019 Q4	12,426,425	$229,759,386	+$44,167,440			$18.49	56
2019 Q3	26,361,341	$365,102,529	+$1,382,126			$13.85	49
2019 Q2	26,070,117	$381,660,468	+$381,660,000			$14.64	46